Abstract
Therapy for type 1 diabetes consists of tight blood glucose (BG) control to minimize complications. Current treatment relies on multiple insulin injections or an insulin pump placement, β-cell or whole pancreas transplantation. All approaches have significant limitations and have led to the realization that novel treatment strategies are needed. Pancreatic acinar cells have features that make them a good target for insulin gene transfer. They are not subject to autoimmune attack, a problem with pancreas or islets transplantation, they are avidly transduced by recombinant adenoviral vectors, and capable of exporting a variety of peptides into the portal circulation. Recombinant adenoviral vectors were engineered to express either wild-type or furin-modified human insulin cDNA (AdCMVhInsM). Immunodeficient mice were made diabetic with streptozotocin and injected intrapancreatically with the vectors. BG and blood insulin levels have normalized after administration of AdCMVhInsM. Immunohistochemistry and electron microscopy showed the presence of insulin in acinar cells throughout the pancreas and localization of insulin molecules to acinar cell vesicles. The data clearly establish a relationship between intrapancreatic vector administration, decreased BG and elevated blood insulin levels. The findings support the use of pancreatic acinar cells to express and secrete insulin into the blood stream. Gene Therapy (2001) 8, 1480–1489.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993 329: 977–986
American Diabetes Association: Clinical Practice Recommendations 2000 . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 2000 23 (Suppl. 1): S1–S116
Screening for Diabetes Mellitus. Guide to Clinical Preventive Services, Second Edition: Screening Metabolic, Nutritional, and Environmental Disorders. U.S. Preventive Services Task Force(www.vnh.org/GCPS2/29.html)
Secchi A et al. Islet transplantation in IDDM patients Diabetologia 1997 40: 225–231
Shapiro AM et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 2000 343: 230–238
Bloomgarden ZT . American Diabetes Association Annual Meeting, 1999. New approaches to insulin treatment and glucose monitoring Diabetes Care 1999 22: 2078–2082
Dafoe DC et al. No improvement of pancreas transplant endocrine function by exogenous insulin infusion (islet rest) in the postoperative period Transplantation 1989 48: 22–62
Levine F, Leibowitz G . Towards gene therapy of diabetes mellitus Mol Med Today 1999 5: 165–171
Matschinsky FM, Glaser B, Magnuson MA . Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities Diabetes 1998 47: 307–315
Lee HC et al. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue Nature 2000 408: 483–488
Kaufmann JE, Irminger JC, Halban PA . Sequence requirements for proinsulin processing at the B-chain/C-peptide junction Biochem J 1995 310: 869–874
Seidah NG, Chretien M . Eukaryotic protein processing: endoproteolysis of precursor proteins Curr Opin Biotechnol 1997 8: 602–607
Kaufmann JE, Irminger JC, Mungall J, Halban PA . Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3 Diabetes 1997 46: 978–982
Steiner DF . The proprotein convertases Curr Opin Chem Biol 1998 2: 31–39
Ohagi S et al. Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM Diabetes 1996 45: 897–901
Steiner DF et al. The role of prohormone convertases in insulin biosynthesis: evidence for inherited defects in their action in man and experimental animals Diabetes Metab 1996 22: 94–104
Dodson G, Steiner D . The role of assembly in insulin's biosynthesis Curr Opin Struct Biol 1998 8: 189–194
Short DK, Okada S, Yamauchi K, Pessin JE . Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice Am J Physiol 1998 275: E748–E756
Nakayama K . Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins Biochem J 1997 327: 625–635
Groskreutz DJ, Sliwkowski MX, Gorman CM . Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin J Biol Chem 1994 25: 6241–6245
Sures I, Goeddel DV, Gray A, Ullrich A . Nucleotide sequence of human preproinsulin complementary DNA Science 1980 208: 57–59
Vollenweider F, Kaufmann J, Irminger JC, Halban PA . Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells Diabetes 1995 44: 1075–1080
Efrat S . Prospects for gene therapy of insulin-dependent diabetes mellitus Diabetologia 1998 41: 1401–1490
Thule PM, Liu J, Phillips LS . Glucose regulated production of human insulin in rat hepatocytes Gene Therapy 2000 7: 205–214
Yamasaki K et al. Differentiation-induced insulin secretion from nonendocrine cells with engineered human proinsulin cDNA Biochem Biophys Res Commun 1999 265: 361–365
Kon OL et al. Naked plasmid-mediated gene transfer to skeletal muscle ameliorates diabetes mellitus J Gene Med 1999 1: 186–194
Mitanchez D et al. Regulated expression of mature human insulin in the liver of transgenic mice FEBS Lett 1998 421: 285–289
Kolodka TM, Finegold M, Moss L, Woo SL . Gene therapy for diabetes mellitus in rats by hepatic expression of insulin Proc Natl Acad Sci USA 1995 92: 3293–3297
Goldfine I et al. The endocrine secretion of human insulin and growth hormone by exocrine glands in the gastrointestinal tract Nat Biotechnol 1997 15: 1378–1382
Cheung AT et al. Glucose-dependent insulin release from genetically engineered K cells Science 2000 290: 1959–1962
Schmid R et al. Direct gene transfer into the rat pancreas using DNA-liposomes Eur J Clin Invest 1998 28: 220–226
Vickers S et al. Adenoviral vector infection of the human exocrine pancreas Arch Surg 1997 132: 1006–1009
DeMatteo R et al. Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter J Surg Res 1997 72: 155–161
Raper S, DeMatteo R . Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas Pancreas 1996 12: 401–410
McClane S, Chirmule N, Burke C, Raper S . Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration Hum Gene Ther 1998 8: 2207–2216
McClane S et al. Effect of adenoviral early genes and the host immune system on in vivo pancreatic gene transfer in the mouse Pancreas 1997 15: 236–245
McClane S, Hamilton T, Burke C, Raper S . Functional consequences of adenovirus-mediated murine pancreatic gene transfer Hum Gene Ther 1997 8: 739–746
McClane S, Hamilton T, Burke C, Raper S . Functional consequences of adenovirus-mediated murine pancreatic gene transfer Hum Gene Ther 1997 8: 739–746
Chan YM, Yu QC, Fine JD, Fuchs E . The genetic basis of Weber–Cockanyne epidermolysis bullosa simplex Proc Natl Acad Sci USA 1993 90: 3544–3548
Yu QC, Allen E, Fuchs E . Desmosomal disorganization and epidermal abnormalities in transgenic mouse expressing mutant desmoglein-3 Proc Microsc Microanal 1996 4: 34–36
Bertera S et al. Immunology of type 1 diabetes. Intervention and prevention strategies Endocrinol Metab Clin North Am 1999 28: 841–864
Tisch R, McDevitt H . Insulin-dependent diabetes mellitus Cell 1996 85: 291–297
Yoon JW, Jun HS, Santamaria P . Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells Autoimmunity 1998 27: 109–122
Wong FS, Janeway CA Jr . Insulin-dependent diabetes mellitus and its animal models Curr Opin Immunol 1999 11: 643–647
Green EA, Flavell RA . The initiation of autoimmune diabetes Curr Opin Immunol 1999 11: 663–669
Iwahashi H et al. Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy Cytokin Cell Mol Ther 1998 4: 45–51
Levine F . Gene therapy for diabetes: strategies for beta-cell modification and replacement Diabetes Metab Rev 1997 13: 209–246
Gros L et al. Insulin production by engineered muscle cells Hum Gene Ther 1999 10: 1207–1217
Wanke IE, Wong NC . Specific problems facing gene therapy for insulin-dependent diabetes mellitus: glucose-regulated insulin secretion from hepatocytes Proc West Pharmacol Soc 1997 40: 131–133
Sugiyama A et al. Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice Horm Metab Res 1997 29: 599–603
Kuzume M et al. Insulin gene transfer can be a new optional therapy for replacement of pancreas Transplant Proc 1998 30: 3416
Auricchio A et al. Regulated insulin gene delivery for treatment of type 1 diabetes Mol Ther 2000 1: S293 (Abstr. 817)
Lipes MA et al. Insulin-secreting non-islet cells are resistant to autoimmune destruction Proc Natl Acad Sci USA 1996 93: 8595–8600
Docherty K . Gene therapy for diabetes mellitus Clin Sci (Colch) 1997 92: 321–330
Ohtani O, Wang QX . Comparative analysis of insulo-acinar portal system in rats, guinea pigs, and dogs Microsc Res Tech 1997 37: 489–496
Abe H, Yamada N, Ishibashi S, Makuuchi M . Chronic inhibitory effect of insulin on plasma lipid concentrations in rats with transplanted pancreas Transplantation 2000 69: 2038–2042
Giannoukakis N, Rudert WA, Robbins PD, Trucco M . Targeting autoimmune diabetes with gene therapy Diabetes 1999 48: 2107–2121
Shifrin AL, Chirmule N, Chapman K, Raper SE . Innate immune response to adenoviral vector-mediated acute pancreatitis J Surg Res 2000 93: 359–360 (Abstr.)
Jooss K, Yang Y, Fisher KJ, Wilson JM . Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers J Virol 1998 72: 4212–4223
Grodsky G . Kinetics of insulin secretion: current implications. In: LeRoith D, Taylor S, Olefsky J (eds) Diabetes Mellitus Lippincott-Raven: Philadelphia 1996 12–20
Kennedy G, German M . Insulin gene regulation. In: LeRoith D, Taylor S, Olefsky J (eds) Diabetes Mellitus Lippincott-Raven: Philadelphia 1996 20–26
Johnson J, Newgard C . The role of glucose transport and phosphorylation in glucose-stimulated insulin secretion. In: LeRoith D, Taylor S, Olefsky J Diabetes Mellitus Lippincott-Raven. Philadelphia 1996 pp 42–49
Rajas F et al. Induction of PEPCK gene expression in insulinopenia in rat small intestine Diabetes 2000 49: 1165–1168
Gros L et al. Regulated production of mature insulin by non-beta-cells Hum Gene Ther 1997 8: 2249–2259
Falqui L . Gene therapy for beta-cell functional replacement in IDDM J Pediatr Endocrinol Metab 1999 12 (Suppl. 3): 789–793
Newgard CB . Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes Biotechnology 1992 10: 1112–1120
Newgard CB . Cellular engineering and gene therapy strategies for insulin replacement in diabetes Diabetes 1994 43: 341–350
Becker TC et al. Differential effects of overexpressed glucokinase and hexokinase I in isolated islets. Evidence for functional segregation of the high and low Km enzymes J Biol Chem 1996 271: 390–394
Maruyama Y, Peterson O . Single-channel currents in isolated patches of plasma membrane from basal surface of pancreatic acini Nature 1982 299: 159–161
Tsuchida T et al. Inhibition of stimulated amylase secretion by adenomedullin in rat pancreatic acini Endocrinology 1999 140: 865–870
Ohnishi H et al. Overexpression of Rab3D enhances regulated amylase secretion from pancreatic acini of transgenic mice J Clin Invest 1997 100: 3044–3052
Ueda N et al. Kinesin is involved in regulation of rat pancreatic amylase secretion Gastroenterology 2000 199: 1123–1131
Acknowledgements
This work was supported by NIH RO1 DK 54207 (SER) NIH DK 47707 (JMW) and the Juvenile Diabetes Research Foundation. Alberto Auricchio is a recipient of a fellowship (371/B) from Telethon Italia. Technical assistance and advice were provided by the Vector Core and Morphology Core of the Institute for Human Gene Therapy and the RIA core, Diabetes Research Center of the University of Pennsylvania.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shifrin, A., Auricchio, A., Yu, QC. et al. Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia. Gene Ther 8, 1480–1489 (2001). https://doi.org/10.1038/sj.gt.3301544
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301544
Keywords
This article is cited by
-
Mapping and targeted viral activation of pancreatic nerves in mice reveal their roles in the regulation of glucose metabolism
Nature Biomedical Engineering (2022)
-
Intra-arterial Targeted Islet-specific Expression of Sirt1 Protects β Cells From Streptozotocin-induced Apoptosis in Mice
Molecular Therapy (2011)
-
The CB1 Receptor Antagonist SR141716A Reverses Adult Male Mice Overweight and Metabolic Alterations Induced by Early Stress
Obesity (2011)
-
Efficient and persistent transduction of exocrine and endocrine pancreas by adeno-associated virus type 8
Journal of Biomedical Science (2007)
-
Molecular Targeting of Pancreatic Disorders
World Journal of Surgery (2005)